Sunday, 20 September 2026European Markets

UNILEVER And L''OREAL Have A High Dividend Yield And Return On Equity In The Household & Personal Products Industry.

Loading stream...

(vianews) - unilever (una.as) is among this list of stock assets with the highest dividend rate and return on equity on the household & personal products industry.

financial asset price forward dividend yield return on equity
unilever (una.as) €43.72 3.9% 39.9%
l''oreal (or.pa) €449.50 1.54% 21.72%

several euronext companies pay out dividends to its shareholders. the dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. unilever (una.as)

3.9% forward dividend yield and 39.9% return on equity

unilever plc operates as a fast-moving consumer goods company. it operates through beauty & wellbeing, personal care, home care, nutrition, and ice cream segments. the beauty & wellbeing segment engages in the sale of hair care products, such as shampoo, conditioner, and styling; skin care products including face, hand, and body moisturizer; and prestige beauty and health & wellbeing products, which includes the vitamins, minerals, and supplements. personal care segment offers skin cleansing products comprising soap and shower, deodorant and oral care products, such as toothpaste, toothbrush, and mouthwash products. home care segment engages in the sale of fabric care including washing powders and liquids, and rinse conditioners; and home and hygiene, fabric enhancers, water and air wellness products. nutrition segment provides the sale of scratch cooking aids, which includes soups, bouillons, and seasonings; dressings products, such as mayonnaise and ketchup; and beverages and functional nutrition products including horlicks and boost, as well as tea products. ice cream segment offers ice cream products including in-home and out-of-home ice creams. it offers its products under the axe, bango, ben & jerry's, cif, comfort, domestos, dove, equilibra, hellmann's, knorr, lux, lifebuoy, liquid i.v., love beauty & planet, magnum, olly, omo, onnit, rexona, seventh generation, smartpants, sunsilk, the vegetarian butcher, vaseline, and wall's brands. the company was founded in 1860 and is headquartered in london, the united kingdom.

earnings per share

as for profitability, unilever has a trailing twelve months eps of €3.26.

pe ratio

unilever has a trailing twelve months price to earnings ratio of 13.41. meaning, the purchaser of the share is investing €13.41 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 39.9%.

more news about unilever.

2. l''oreal (or.pa)

1.54% forward dividend yield and 21.72% return on equity

l'oréal s.a., through its subsidiaries, manufactures and sells cosmetic products for women and men worldwide. the company operates through four divisions: consumer products, l'oréal luxe, professional products, and active cosmetics. it offers shampoos, hair care products, shower gels, skincare products, cleansers, hair colorants, deodorants, sun care products, make-up, perfumes, etc. the company provides its products under the l'oréal paris, garnier, maybelline new york, nyx professional makeup, stylenanda, essie, dark & lovely, mixa, magic mask, niley, lancôme, yves saint laurent, armani, kiehl's since 1851, halena rubinstein, biotherm, shu uemura, it cosmetics, ralph lauren fragrance, urban decay, mugler, valentino, viktor&rolf, azzaro, prada, cacharel, maison margela fragrance, diesel, yue sai, atelier colonge, carita, takami, l'oréal professionnel paris, kérastase, redken, matrix, pureology, pulp riot, la roche-posay, vichy, cerave, skinceuticals, decléor, and skinbetter science brands. it sells its products through distribution channels, such as hair salons, local stores, e-commerce, travel retail, mass market retail, department store perfumeries, pharmacies, drug stores, medi-spas, and branded retail. l'oréal s.a. was founded in 1909 and is headquartered in clichy, france.

earnings per share

as for profitability, l''oreal has a trailing twelve months eps of €10.88.

pe ratio

l''oreal has a trailing twelve months price to earnings ratio of 41.31. meaning, the purchaser of the share is investing €41.31 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 21.72%.

volatility

l''oreal's last week, last month's, and last quarter's current intraday variation average was a negative 0.19%, a positive 0.18%, and a positive 0.75%.

l''oreal's highest amplitude of average volatility was 0.19% (last week), 0.43% (last month), and 0.75% (last quarter).

dividend yield

as stated by morningstar, inc., the next dividend payment is on apr 27, 2023, the estimated forward annual dividend rate is 6 and the estimated forward annual dividend yield is 1.54%.

more news about l''oreal.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Boom Hits a Fork: Slowdown Calls Clash with Capex Confidence as Markets Get Nervous
Dario Amodei's repeated calls for a global slowdown in frontier AI development, echoed by Microsoft's new humanist AI code of conduct and FTC antitrust caution, are being publicly rejected by Nvidia and Meta leadership even as hyperscaler spending draws fresh skeptical scrutiny (Wachter's analysis, Burry-style overbuilding worries) and weak guidance from Adobe and a post-slowdown-comment selloff in GE Vernova signal investor jitters. Meanwhile wealth and security effects of the AI race keep compounding — Zhang Yiming's fortune surging on AI-driven ByteDance value, a Chinese hacking firm weaponizing AI against stolen government secrets, and low-quality AI-generated products (an AI sitcom, a spam-flooding agent platform) fueling backlash even as adoption races ahead.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Berkshire Hathaway
Both facts report Berkshire Hathaway's cash position on 2026-01-01 with identical observation timestamps, but claim vastly different values: 380 billion USD vs 400 USD. These cannot both be true for the same entity at the same point in time. The magnitude of the discrepancy (a factor of ~10^9) rules out rounding, unit conversion, or methodological differences.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,982
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,982 facts checked against source5,299 source documents archived
Query this data → isubstrate.com